Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-12-20
1998-05-26
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546148, 546149, 546150, C07D40100, C07D21718, C07D21700, A01N 4342
Patent
active
057565163
ABSTRACT:
The invention relates to compounds of formula (I) ##STR1## wherein R.sup.1 is an optional substituent any position of phenyl ring and is selected from halogen, --NO.sub.2, --NH.sub.2, --OH and --O--CR.sub.1-6 alkyl;
REFERENCES:
patent: 3282944 (1966-11-01), Walker et al.
patent: 4404216 (1983-09-01), Richardson
"Chapter 2: Ergosterol Biosynthesis Inhibitors" in Scrip's Antifungal Report--A review of progress in the development of new antifungals (PJB Publications Ltd., BS 460) Sep. 1992, pp. 13-49.
Chen Hsiao-Jen
Huang Hsiang-Ling
Lin Mei-Shey
Lin Ya-Chuan
Liu Lee-Tai
Development Center for Biotechnology
Ford John M.
Ngo Tamthom T.
LandOfFree
1,2,3,4-tetrahydroisoquinoline derivatives and pharmaceutical co does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,2,3,4-tetrahydroisoquinoline derivatives and pharmaceutical co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2,3,4-tetrahydroisoquinoline derivatives and pharmaceutical co will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1960509